Source: Eur Respir J 2015; 46: 297-298
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vachiery Jean-Luc, Rubin Lewis J.. Navigating the uncharted waters of combination therapy in pulmonary arterial hypertension: COMPASS or dead-reckoning. Eur Respir J 2015; 46: 297-298

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension: combination therapy in the modern management era Source: Eur Respir Rev 2010 19: 348-349 Year: 2010 Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Source: Eur Respir J 2014; 44: 1404-1407 Year: 2014 Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better? Source: Eur Respir J 2006 Oct 01;28(4):683-686 Year: 2006 Applying pharmacogenomics to pulmonary arterial hypertension (PAH): A target-based approach to therapy Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Challenges in the diagnosis and treatment of pulmonary arterial hypertension Source: Eur Respir Rev 2012 21: 313-320 Year: 2012 New horizons in pulmonary arterial hypertension management Source: Eur Respir Rev 2014; 23: 408-409 Year: 2014 Optimal management of severe pulmonary arterial hypertension Source: Eur Respir Rev 2011; 20: 254-261 Year: 2011 Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension Source: Eur Respir Rev, 30 (162) 210161; 10.1183/16000617.0161-2021 Year: 2021 Repurposing benzbromarone for pulmonary arterial hypertension: can channelling the past deliver the therapy of the future? Source: Eur Respir J, 53 (6) 1900583; 10.1183/13993003.00583-2019 Year: 2019 Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled Source: Eur Respir Rev, 26 (146) 170093; 10.1183/16000617.0093-2017 Year: 2017 New horizons in pulmonary arterial hypertension therapies Source: Eur Respir Rev 2013; 22: 503-514 Year: 2013 Pulmonary arterial hypertension: tailoring treatment to risk in the current era Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017 Year: 2017 Upfront triple therapy for pulmonary arterial hypertension: is three a crowd or critical mass? Source: Eur Respir J 2014; 43: 1556-1559 Year: 2014 Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Combination therapy for pulmonary arterial hypertension: still more questions than answers Source: Eur Respir J 2004; 24: 339-340 Year: 2004 Optimising the management of pulmonary arterial hypertension patients: emergency treatments Source: Eur Respir Rev 2010 19: 204-211 Year: 2010 Initial dual oral combination therapy for pulmonary arterial hypertension (PAH) in daily practice Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Pulmonary arterial hypertension: treatment options Source: International Congress 2018 – ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED Year: 2018 Current medical treatment of pulmonary arterial hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Current medical treatment of pulmonary arterial hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014